000898.SZ
000898.SZ
CNE000000SQ4
ANSC
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)
1.08x
Above average
Volatility (5Y p.a.)
28.7% p.a.
5-Year Horizon
Max Drawdown (5Y)
-61.8%
5-Year Horizon
Sharpe Ratio
-0.61
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -25.5%
3 Years 29.1% -35.6% -0.38 -8.6%
5 Years 28.7% -61.8% -0.61 -15.3%
10 Years 33.1% -72.7% -0.24 -5.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -72.7% in the extended horizon.
ende